US 11655307
Anti-doublecortin-like kinase 1 antibodies and methods of use
granted A61KA61K2039/505A61K47/6871
Quick answer
US patent 11655307 (Anti-doublecortin-like kinase 1 antibodies and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K47/6871, A61P, A61P35/00